Relapsing-Remitting Multiple Sclerosis Plasma | High-Quality Human Plasma from Relapsing-Remitting Multiple Sclerosis (RRMS) Donors

Relapsing-Remitting Multiple Sclerosis Plasma is collected from donors clinically diagnosed with relapsing-remitting multiple sclerosis (RRMS) and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human RRMS plasma supports research focused on biomarker discovery and monitoring, and treatment development for RRMS.

Product Features

• Research Use Only (RUO)
• RRMS plasma collected from clinically confirmed donors
• Processed within one day of collection
• IRB-approved protocols and informed consent
• Custom aliquot volumes available upon request

Donor Metadata

• Verified RRMS diagnosis
• Demographic data: age, sex assigned at birth, race/ethnicity
• Donor-reported medications, allergies, and comorbidities
• Additional RRMS-specific metadata available

Applications

• Biomarker discovery and validation
• Cytokine and inflammation profiling
• Metabolomics and proteomics studies
• Therapeutic response research

Compliance and Quality Assurance

• IRB-approved and HIPAA-compliant protocols
• Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
• Documentation support available for regulatory review

Ordering and Customization

Relapsing-Remitting Multiple Sclerosis plasma is available in standard and custom volumes. For international orders or documentation requirements, please email [email protected] to ensure compatibility with your country’s regulations.